Key facts
- It has raised $1.7M.
- Notable investors include Johns Hopkins Technology Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sotelix Endoscopy
- ·The full record, as it builds
Funding rounds
No funding rounds for Sotelix Endoscopy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sotelix Endoscopy
Developer of medical equipment designed to offer minimally invasive treatment of obesity and metabolic disorders. The company offers therapeutic endoscopy devices for minimally invasive therapies in the gastrointestinal tract, enabling healthcare professionals to utilize advanced technology for their surgical treatments.
- Sector
- Healthcare
- HQ
- Towson, MD, United States
- Founded
- 2024
- Employees
- 6
- Website
- sotelix.com/
- Ownership
- Privately Held (backing)
Sotelix Endoscopy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sotelix Endoscopy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sotelix Endoscopy in its N-PORT filings yet. We sweep new filings monthly.